CLEC2D and cancer: Similarly, LLT1 expression on CD14+ monocytes was significantly increased in very high-risk, high-risk, and standard risk/low-risk ALL subjects in comparison to their healthy counterparts (Figure 4E), suggesting that the high expression of LLT1 in different cell types could be a major contributor to cancer prognosis and risk in ALL.